NPI: 1194048702 · EVERETT, WA 98203 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/10/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/10/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,041 | $319K |
| 2019 | 20,667 | $431K |
| 2020 | 21,488 | $297K |
| 2021 | 16,392 | $259K |
| 2022 | 11,099 | $260K |
| 2023 | 7,777 | $257K |
| 2024 | 2,972 | $257K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36,715 | 2,368 | $1.93M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,498 | 1,312 | $63K |
| A4657 | Syringe, with or without needle, each | 2,930 | 1,531 | $48K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 380 | 169 | $19K |
| J1756 | Injection, iron sucrose, 1 mg | 5,672 | 1,210 | $13K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,981 | 1,007 | $2K |
| 0012A | 14 | 12 | $40.00 | |
| 90674 | 39 | 29 | $28.13 | |
| 0011A | 18 | 15 | $16.94 | |
| 85048 | 1,342 | 924 | $0.00 | |
| 85041 | 1,343 | 926 | $0.00 | |
| 83540 | 1,034 | 742 | $0.00 | |
| 83970 | 961 | 644 | $0.00 | |
| 82108 | 45 | 36 | $0.00 | |
| 90662 | 28 | 25 | $0.00 | |
| 82728 | 1,047 | 757 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 259 | 121 | $0.00 |
| 83550 | 961 | 698 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 120 | 93 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 49 | 38 | $0.00 |